Sign inSubscribe
Headlines

BF Biosciences enters contract manufacturing deal with Lucky Core Industries

Agreement covers production of Esopase IV 40 mg and Etipro IV 40 mg

By News Desk

BF Biosciences Limited (BFBL), a subsidiary of Ferozsons Laboratories Limited, has signed a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI). 

The agreement involves the production of two pharmaceutical products: Esopase IV 40 mg and Etipro IV 40 mg.

This development was communicated by Ferozsons Laboratories in accordance with Section 96 of the Securities Act, 2015, and Clause 5.6.1(a) of PSX Regulations. 

The company requested that the relevant information be disseminated to the TREC Holders of the Pakistan Stock Exchange. 

Previous article
India’s economy to remain strong despite subdued global growth: World Bank 
Next article
Pakistan’s exports surge by 16% in August, hitting $2.74 billion
News Desk
News Desk

RELATED ARTICLES

Must Read

World Business News

India’s Adani bans entry of sanctioned ships at its ports, sources...

Move could disrupt Russian oil supplies for two Indian refiners, as Moscow’s oil is primarily shipped by a shadow fleet following Western sanctions

Thal Limited approves $16 million investment for grain storage and milling facility in Muzaffargarh

At-Tahur approves establishment of wholly-owned subsidiary in Pakistan

Pakistan eyes Bangladesh market to boost cement exports

Profit by Pakistan Today
Publishing Editor: Babar Nizami -- Editor Multimedia: Umar Aziz Khan -- Senior Editor: Abdullah Niazi -- Editorial Consultant: Ahtasam Ahmad -- Business Reporters: Taimoor Hassan | Shahab Omer l Zain Naeem | Shahnawaz Ali | Ghulam Abbass | Ahmad Ahmadani | Aziz Buneri -- Sub-Editor: Saddam Hussain -- Video Producer: Talha Farooqi -- Director Marketing : Mudassir Alam | Regional Heads of Marketing: Agha Anwer (Khi) | Kamal Rizvi (Lhe) | Malik Israr (Isb ) -- Manager Subscriptions: Irfan Farooq -- Pakistan’s #1 business magazine - your go-to source for business, economic and financial news.
Contact us: [email protected]
Copyright © 2025. Pakistan Today. All Rights Reserved.